Drug intelligence / Profile preview

Sante PC

Development stage
Unknown
Lead developer
Santen Pharmaceutical
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Sante PC is a **multi-ingredient ophthalmic small-molecule OTC eye drop** developed and manufactured by Santen Pharmaceutical for relief of eye fatigue and ocular surface/conjunctival symptoms associated with prolonged computer and smartphone use, including exposure to blue light. The formulation combines cyanocobalamin, sodium chondroitin sulfate, pyridoxine hydrochloride, neostigmine methyl sulfate, taurine, dipotassium glycyrrhizinate, chlorpheniramine maleate, and tetrahydrozoline hydrochloride to provide a multipronged pharmacologic effect: support of accommodative function, corneal surface protection, tissue metabolic support, anti-inflammatory and anti-allergic activity, and vasoconstriction to reduce conjunctival hyperemia. It is marketed in Japan as a Class 2 OTC ophthalmic medicine for eye fatigue, conjunctival hyperemia, eye inflammation caused by light exposure, itchy eyes, and prevention of eye disease.

Brand names
Sante PC
02

Targets

HRH1 (Histamine H1 Receptor)mAChR (Muscarinic acetylcholine receptors)ADRA1 (Alpha-1 adrenergic receptor family)

Beyond the preview

Go deeper on Sante PC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sante PC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call